Given that a laser can be introduced intravesically via a cystoscope and the US FDA has approved both laser interstitial thermal therapy and PD-L1 based immunotherapy, the SYMPHONY therapy could provide an effective treatment when an aggressive tumor cannot be surgically resected. This evidence concerns the gene CD274 and neoplasm.